Understanding Mortality Trends in People Living with HIV

For decades, the narrative surrounding HIV has shifted from a terminal diagnosis to a manageable chronic condition. With the advent of highly active antiretroviral therapy (ART) in the mid-1990s, mortality rates for people living with HIV have declined dramatically. However, as the population of people living with HIV ages, the clinical picture has become more complex. Understanding why mortality occurs in this community today requires looking beyond the virus itself and examining the evolving landscape of comorbidities.

The Shift in Causes of Death

Recent longitudinal research published in The Lancet HIV highlights how the causes of death for people living with HIV have evolved. By analyzing data from over 189,000 individuals across North America and Europe who began treatment between 1996 and 2020, researchers have identified a clear transition in health outcomes.

While AIDS-related complications were once the primary cause of mortality, they now share the stage with non-communicable diseases. According to the study, the most common causes of death observed over the study period were:

• AIDS-related illnesses (25%)
• Non-AIDS and non-liver-related cancers (14%)
• Cardiovascular or heart disease (8%)

The all-cause mortality rate saw a significant improvement, falling from 16.8 deaths per 1,000 person-years during the 1996–1999 period to 7.9 per 1,000 during 2016–2020.

Why Comorbidities Matter

As treatment has become more effective, the life expectancy for those who start ART promptly now approaches that of the general population. This success brings new challenges. As people living with HIV age, they face the same risks for chronic conditions—such as heart disease, metabolic disorders, and various cancers—as their HIV-negative peers.

Clinicians must now balance HIV viral suppression with the proactive management of these age-related health issues. The persistence of disparities in mortality outcomes suggests that access to care, lifestyle factors, and the long-term impact of systemic inflammation continue to play critical roles in patient health.

Key Takeaways

• Significant Progress: Mortality rates among people living with HIV have been cut in half over the last three decades due to advancements in ART.
• Evolving Risks: While HIV-specific mortality has decreased, non-AIDS-related conditions like cardiovascular disease and cancer represent a growing portion of mortality data.
• Long-Term Management: Modern HIV care focuses on a holistic approach that treats the patient’s overall health rather than focusing solely on viral load suppression.

Frequently Asked Questions

Is HIV still considered a terminal illness?

No. For individuals who have access to and maintain consistent antiretroviral therapy, HIV is classified as a chronic, manageable health condition. Most patients on effective treatment can expect a near-normal life expectancy.

Why do people living with HIV still face higher risks for certain cancers or heart disease?

Research suggests that chronic inflammation, the aging process, and the cumulative effects of living with a viral infection—even when suppressed—can contribute to a higher prevalence of non-AIDS-related comorbidities. Regular screenings for cardiovascular health and cancer are essential components of modern HIV care.

What should patients discuss with their doctors?

Patients should prioritize regular check-ups that include not only viral load and CD4 count monitoring but also screenings for blood pressure, cholesterol, glucose levels, and age-appropriate cancer screenings. Open communication about overall health, lifestyle, and family history is vital for long-term well-being.

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with your healthcare provider regarding your specific medical needs and treatment plans.